C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in...
39 KB (3,272 words) - 11:00, 31 July 2024
Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and...
7 KB (655 words) - 05:48, 7 April 2024
Mainz-Bingen. Furthermore, Ingelheim harbours the business Boehringer Ingelheim which is active worldwide. In 2004, 36% of Ingelheim's inhabitants belonged...
36 KB (3,515 words) - 08:32, 20 August 2024
{h}}]}{{\text{output per step}}[{\ce {kg}}]}}} The process chemistry group at Boehringer Ingelheim, for example, targets a VTO of less than 1 for any given synthetic...
31 KB (4,405 words) - 05:18, 27 December 2023
Boehringer (Böhringer) may refer to: Boehringer Ingelheim, a pharmaceutical company Boehringer Laboratories, an American medical technology company Boehringer...
760 bytes (106 words) - 22:05, 7 February 2024
[dead link] "Boehringer Ingelheim Financial Highlights 2023". "Boehringer Ingelheim Financial Report 2022" (PDF). "Boehringer Ingelheim Summary Report...
61 KB (2,699 words) - 04:11, 10 June 2024
Biberach an der Riß (section Boehringer Ingelheim)
January, 2022. Boehringer Ingelheim researches, develops and produces pharmaceuticals. Boehringer Ingelheim was founded in Ingelheim am Rhein, Germany...
13 KB (1,099 words) - 09:18, 20 August 2024
inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. Its activity at the dopamine transporter is six times stronger than...
34 KB (3,319 words) - 19:30, 3 August 2024
Hubertus von Baumbach (category Boehringer Ingelheim people)
chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company. The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von...
6 KB (445 words) - 19:50, 23 August 2024
Meloxicam (category Drugs developed by Boehringer Ingelheim)
for medical use in the United States in 2000. It was developed by Boehringer Ingelheim; however, it is also available as a generic medication. In 2021,...
39 KB (3,755 words) - 15:06, 1 July 2024
Ponazuril (INN), sold by Merial, Inc., now part of Boehringer Ingelheim, under the trade name Marquis® (15% w/w ponazuril), is a drug currently approved...
4 KB (168 words) - 13:29, 29 May 2024
in the city, including Eli Lilly and Company, Procter & Gamble, Boehringer Ingelheim, and Nestlé. The city is the point of origin and namesake of Kobe...
63 KB (4,727 words) - 09:53, 18 August 2024
the biggest draw back of the jet nebulizer. The medical company Boehringer Ingelheim also invented a device named Respimat Soft Mist Inhaler in 1997....
24 KB (2,801 words) - 12:12, 30 May 2024
Metformin (category Drugs developed by Boehringer Ingelheim)
Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in...
149 KB (14,314 words) - 15:32, 18 August 2024
the project, while Boehringer Ingelheim could receive more than $800 million from development of the new drugs. Boehringer Ingelheim's oral anti-diabetic...
165 KB (15,040 words) - 02:05, 15 August 2024
excessive mucus. It was developed in the research laboratory of Boehringer Ingelheim in the late 1950s as an active ingredient for pharmaceutical use...
4 KB (300 words) - 02:40, 26 June 2024
Survodutide (category Drugs developed by Boehringer Ingelheim)
analog rather than an analog of oxyntomodulin. It is developed by Boehringer Ingelheim as a weight loss drug. Klein, Thomas; Augustin, Robert; Hennige,...
7 KB (207 words) - 18:46, 16 June 2024
Heinrich Otto Wieland (category Boehringer Ingelheim people)
teach at the university and starting in 1907 was a consultant for Boehringer Ingelheim.[citation needed] In 1914 he became associate professor for special...
8 KB (712 words) - 09:23, 20 August 2024
disease (COPD), and other respiratory conditions. Its developer, Boehringer Ingelheim, is currently[when?] conducting approved in the U.S. with a variety...
1 KB (93 words) - 18:59, 24 August 2022
Johannes Gutenberg University in Mainz, Germany. It is funded by the Boehringer Ingelheim Foundation and the state of Rheinland Palatinate. The scientists...
15 KB (1,468 words) - 16:16, 29 June 2024
Nintedanib (category Drugs developed by Boehringer Ingelheim)
and platelet derived growth factor receptor. Ofev was developed by Boehringer Ingelheim. It received U.S. Food and Drug Administration (FDA) approval for...
34 KB (3,021 words) - 12:39, 5 August 2024
Empagliflozin (category Drugs developed by Boehringer Ingelheim)
SGLT-2 over SGLT-1, SGLT-4, SGLT-5 and SGLT-6. It was developed by Boehringer Ingelheim and is co-marketed by Eli Lilly and Company. It is also available...
39 KB (3,488 words) - 17:59, 16 August 2024
Chewable Tablets Cardiac drug for oral use in dogs only" (PDF). Boehringer Ingelheim Vetmedica, Inc. 2007. Archived from the original (PDF) on 6 February...
14 KB (1,266 words) - 17:48, 27 July 2024
university. Until 1920 he was the head of the family firm C.H. Boehringer in Ingelheim. From 1931 he took part in the establishment of Hoffmann-La Roche...
2 KB (221 words) - 20:58, 28 December 2021
Torosyan v. Boehringer Ingelheim Pharmaceuticals, Inc., 662 A2d 89 (1995) is a US labor law case, concerning the contract of employment in state law for...
1 KB (148 words) - 15:51, 11 March 2024
United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. Of the gliflozins, empagliflozin and tofogliflozin have the highest...
44 KB (4,559 words) - 22:03, 7 July 2024
difficulty falling asleep or staying asleep and dry mouth. Development by Boehringer Ingelheim was halted in October 2010, following a negative evaluation by the...
31 KB (3,208 words) - 03:52, 14 August 2024
Dabigatran (category Drugs developed by Boehringer Ingelheim)
July 2014, a series of investigations accused the privately held Boehringer Ingelheim pharmaceutical group of withholding critical information about the...
41 KB (3,733 words) - 13:41, 14 June 2024
Ipratropium bromide/salbutamol (category Drugs developed by Boehringer Ingelheim)
Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary...
6 KB (363 words) - 22:34, 23 August 2024
UK. It is marketed by various companies under licence, including Boehringer Ingelheim and CSL. Tamsulosin hydrochloride extended-release capsules are marketed...
17 KB (1,427 words) - 08:26, 1 July 2024